USP24 and cancer: The DisGeNET knowledge platform’s analyses found USP24 dysregulation to be associated with LDL-C levels (gene-disease score, GDA = 1), Parkinson disease (GDA 0.08), and various cancer types (GDA = 0.04–0.01) including lung cancer, multiple myeloma, T-cell lymphoma, and neuroblastoma [39].